non-specific beta-adrenergic receptor antagonist (non-specific beta-blocker)
Jump to navigation
Jump to search
Introduction
beta blockers without specificity for beta-1 adrenergic receptors vs beta-2 adrenergic receptors
Monitor
Adverse effects
- may mask symptoms of hypoglycemia
- non-selective beta blockers can inhibit glucose release & increase sensitivity to insulin by impairing adrenergic response
- effect is uncommon & usually mild[1]
- non-selective beta blockers can inhibit glucose release & increase sensitivity to insulin by impairing adrenergic response
- drug adverse effects of beta-adrenergic receptor antagonists
- drug adverse effects of renin-angiotensin-aldosterone system inhibitors (RAAS inhibitors)
- drug adverse effects of antihypertensive agents
More general terms
More specific terms
- bucindolol
- carteolol (Cartrol, Ocupress)
- carvedilol (Coreg)
- labetalol (Trandate, Normodyne, Ibidomide, Dilevolol)
- levobunolol (Betagan, Gotensin, Vistagan)
- metipranolol (Optipranolol)
- nadolol (Corgard)
- penbutolol (Levatol)
- pindolol (Visken)
- propranolol (Inderal, InnoPran)
- sotalol (Betapace, Sotacor)
- timolol (Blocadren, Timoptic, Betimol, Istalol)